November 18, 2026 Experience Charles River Laboratories acquisition of Frontage’s bioanalysis and DMPK businesses We are advising Charles River on the transaction
November 16, 2026 Experience vVARDIS $175 million IPO We are advising vVARDIS on its IPO and NYSE listing
October 22, 2026 Experience QIAGEN $12.1 billion takeover offer by EQT Private Equity We are advising QIAGEN on the transaction
October 6, 2026 Experience McKesson $1.4 billion investment in Option Care Health We are advising McKesson on the transaction
August 25, 2026 Experience McKesson $2.25 billion acquisition of Precision Medicine Group We are advising McKesson on the transaction
August 4, 2026 Experience PetIQ acquisition of MYOS We advised Bansk Group and its portfolio company PetIQ on the transaction
July 31, 2026 Experience athenahealth $500 million senior secured notes offering We advised the initial purchasers on the high-yield notes offering
July 6, 2026 Experience Clarivate sale of Life Sciences & Healthcare segment to Altaris We are advising Clarivate on the transaction
June 18, 2026 Experience PTC Therapeutics $550 million convertible senior notes offering We advised the initial purchasers on the offering
June 12, 2026 Experience TARGAN sale to Merck Animal Health We are advising TARGAN on the transaction